Calmodulin 2 (CALM2)

📖 Wiki Page

protein749 wordssynced 2026-04-02

Calmodulin 2 (CALM2)

Introduction

Calmodulin 2 (CALM2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@pmidhttpspubmedncbinlmnihgov2002]
<table> [@pmidhttpspubmedncbinlmnihgov2016]
<tr><th colspan="2" style="background:#e8f4ea;">Calmodulin 2</th></tr> [@pmidhttpspubmedncbinlmnihgov2015]
<tr><td><b>Protein Name</b></td><td>Calmodulin 2</td></tr> [@pmidhttpspubmedncbinlmnihgov2007]
<tr><td><b>Gene</b></td><td>[CALM2](/genes/calm2)</td></tr> [@pmidhttpspubmedncbinlmnihgov2017]
<tr><td><b>UniProt ID</b><a href="https</td><td>://www.uniprot.org/uniprot/P0DP24">P0DP24</a></td></tr> [@pmidhttpspubmedncbinlmnihgov2019]
<tr><td><b>Molecular Weight</b></td><td>16.8 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Cytoplasm, Nucleus</td></tr>
<tr><td><b>Protein Family</b></td><td>EF-hand calcium-binding protein family</td></tr>
<tr><td><b>Associated Diseases</b></td><td>Long QT syndrome, CPVT, Cardiac arrhythmias, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

...

Calmodulin 2 (CALM2)

Introduction

Calmodulin 2 (CALM2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

Calmodulin is a ubiquitous calcium-binding protein with four EF-hand domains. It regulates over 100 target proteins including kinases, phosphatases, ion channels, and transcription factors. In the nervous system, calmodulin serves as the primary calcium sensor, translating changes in intracellular Ca2+ concentration into downstream signaling events that control synaptic plasticity, neuronal excitability, and cell survival [1][2].

Structure

The CALM2 protein belongs to the EF-hand calcium-binding protein family:

Four EF-hand Domains: Each EF-hand consists of a conserved 12-residue loop flanked by two α-helices (E and F helices)
N-terminal Domain: Contains EF-hands 1 and 2, with lower Ca²⁺ affinity
C-terminal Domain: Contains EF-hands 3 and 4, with higher Ca²⁺ affinity
Central Linker: Flexible linker allows conformational changes upon Ca²⁺ binding

Upon Ca²⁺ binding, calmodulin undergoes a dramatic conformational change, exposing hydrophobic patches that mediate interactions with target proteins [1].

Normal Function in the Nervous System

Calcium Signal Transduction

Calmodulin serves as the primary calcium sensor in [neurons](/entities/neurons):

Ca²⁺ Binding: Rising intracellular Ca²⁺ binds to calmodulin's EF-hands

Conformational Change: Ca²⁺-bound calmodulin adopts an open conformation

Target Recognition: Hydrophobic patches interact with target proteins

Signal Modulation: Calmodulin activates or inhibits target enzymes

Key Neuronal Targets

CaMKII/IV: Calcium/calmodulin-dependent protein kinases critical for synaptic plasticity
Calcineurin: Calcium-activated phosphatase that dephosphorylates NFAT
cAMP Phosphodiesterases: Regulate second messenger signaling
Ion Channels: Modulate [NMDA](/entities/nmda-receptor) receptors, voltage-gated Ca²⁺ channels
Transcription Factors: Activate CREB and other Ca²⁺-responsive genes

Synaptic Function

Synaptic Plasticity: CaM/CaMKII signaling is essential for [LTP](/mechanisms/long-term-potentiation) and LTD
Neurotransmitter Release: Regulates vesicle fusion machinery
Dendritic Spine Morphogenesis: Controls spine formation and remodeling
Gene Expression: Activates CREB-mediated transcription for long-term changes

Role in Disease

Alzheimer's Disease

Calmodulin dysfunction contributes to AD pathogenesis through multiple mechanisms:

Amyloid-β Toxicity: [Aβ](/proteins/amyloid-beta) peptides disrupt Ca²⁺ homeostasis, altering calmodulin signaling
[Tau](/proteins/tau) Phosphorylation: CaMKII dysregulation affects [tau](/proteins/tau) kinase/phosphatase balance
Synaptic Failure: Impaired CaM/CaMKII signaling contributes to synaptic loss
Therapeutic Target: Calmodulin antagonists explored as neuroprotective agents [3][4]

Parkinson's Disease

Calmodulin modulates dopaminergic neuron survival:

[α-Synuclein](/proteins/alpha-synuclein) Aggregation: Ca²⁺ binding to α-synuclein promotes fibril formation
Mitochondrial Dysfunction: Calmodulin regulates calcium handling in mitochondria
LRRK2 Kinase Activity: Calmodulin interacts with LRRK2, a PD risk gene
Neuroprotection: Calmodulin inhibitors may protect against excitotoxicity [5]

Cardiac Arrhythmias (Long QT/CPVT)

CALM2 mutations cause cardiac channelopathies:

LQT15/CAV3: CALM1, CALM2, CALM3 mutations cause long QT syndrome type 15
CPVT4: Mutations disrupt Ca²⁺/calmodulin-dependent signaling in cardiac myocytes
Mechanism: Mutations alter Ca²⁺ binding affinity or target protein interactions

ALS/FTD

Calmodulin dysfunction may contribute to motor neuron disease:

[TDP-43](/proteins/tdp-43) Pathology: Altered Ca²⁺ signaling affects [TDP-43](/mechanisms/tdp-43-proteinopathy) aggregation
RNA Metabolism: Calmodulin regulates RNA-binding proteins implicated in ALS
Excitotoxicity: Dysregulated Ca²⁺ homeostasis contributes to motor neuron death [6]

Therapeutic Targeting

Modulating calmodulin function represents therapeutic strategies:

Current Approaches

Calmodulin Antagonists: W-7, calmidazolium for research; limited CNS penetration
Target-Specific Modulators: Compounds targeting CaMKII or calcineurin
Calcium Homeostasis Modulators: FDA-approved drugs affecting Ca²⁺ channels

Research Directions

[Blood-Brain Barrier](/entities/blood-brain-barrier) Penetration: Developing CNS-active calmodulin inhibitors
Allosteric Modulators: Targeting specific protein-protein interactions
Gene Therapy: Restoring normal CALM2 expression or function

Pathway Interactions

Calmodulin participates in key neuronal signaling pathways:

[Calcium Signaling Pathway](/mechanisms/calcium-signaling-pathway) - Primary calcium sensor
[Synaptic Plasticity Pathway](/mechanisms/synaptic-plasticity) - CaMKII activation
[CREB Signaling Pathway](/mechanisms/creb-signaling-pathway) - Transcription activation
[Apoptosis Pathway](/mechanisms/apoptosis-neurodegeneration) - Pro-survival signaling

Interacting Proteins

[CaMKII](/proteins/camk2) - Calcium/calmodulin-dependent protein kinase II
[Calcineurin](/proteins/calcineurin) - Calcium-activated phosphatase
[NMDA Receptor](/entities/nmda-receptor) - Glutamate receptor
[CREB](/proteins/creb) - Transcription factor
[α-Synuclein](/proteins/snca-protein) - Parkinson's disease protein
[LRRK2](/proteins/lrrk2) - Parkinson's disease kinase

Background

The study of Calmodulin 2 (Calm2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Calmodulin 2 (CALM2) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Calmodulin 2 (CALM2)

Calmodulin 2 (CALM2)

Introduction

Overview

Calmodulin 2 (CALM2)

Introduction

Overview

Structure

Normal Function in the Nervous System

Calcium Signal Transduction

Key Neuronal Targets

Synaptic Function

Role in Disease

Alzheimer's Disease

Parkinson's Disease

Cardiac Arrhythmias (Long QT/CPVT)

ALS/FTD

Therapeutic Targeting

Current Approaches

Research Directions

Pathway Interactions

Interacting Proteins

Background

See Also

Pathway Diagram